SPECTRUM PHARMACEUTICALS, INC.

Inactive Instrument

Analyst Reco. Spectrum Pharmaceuticals, Inc.

Equities

SPPI

US84763A1088

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Downgrades Spectrum Pharmaceuticals to Hold From Buy, Cuts Price Target to $1.50 From $3.50	23-05-15	MT
B. Riley Lifts Spectrum Pharmaceuticals' Price Target to $1.14 From $1 on Heels of Announced Sale to Assertio Holdings, Keeps Neutral Rating	23-05-08	MT
JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Market Outperform	23-04-26	MT
HC Wainwright Downgrades Spectrum Pharmaceuticals to Neutral From Buy	23-04-26	MT
JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Outperform	23-04-26	MT
Cantor Fitzgerald Adjusts Spectrum Pharmaceuticals' Price Target to $0.75 From $3, Maintains Neutral Rating	23-02-03	MT
HC Wainwright Trims Price Target on Spectrum Pharmaceuticals to $4 From $6, Maintains Buy Rating	22-11-28	MT
Fed Rate Policy Outlook Buoys Exchange-Traded Funds, Equities Futures Premarket Friday	22-11-25	MT
B. Riley Downgrades Spectrum Pharmaceuticals to Neutral From Buy, Trims PT to $1 From $1.50 Due to Elevated Uncertainty on Poziotinib Prospects, Challenging Near-Term Catalyst Profile	22-11-16	MT
HC Wainwright Lowers Spectrum Pharmaceuticals Price Target to $6 From $9, Maintains Buy Rating	22-09-23	MT
Jefferies Adjusts Spectrum Pharmaceuticals' Price Target to $3.50 from $7, Maintains Buy Rating	22-09-23	MT
B. Riley Securities Lowers Spectrum Pharmaceuticals' Price Target to $1.50 from $4 on Discounted Cash Flow Analysis, Retains Buy Rating	22-09-23	MT
HC Wainwright Adjusts Price Target on Spectrum Pharmaceuticals to $9 From $12, Reiterates Buy Rating	22-09-20	MT
HC Wainwright Adjusts Spectrum Pharmaceuticals' Price Target to $12 from $10, Maintains Buy Rating	22-09-12	MT
B. Riley Lowers Spectrum Pharmaceuticals' Price Target to $4 from $6 to Account for Slightly Delayed Market Entry of Pozi, Efla; Keeps Buy Rating	22-03-21	MT
SPECTRUM PHARMACEUTICALS : B. Riley Lowers Spectrum Pharmaceuticals' PT to $6 from $8 on 'Disappointing' ROLONTIS Complete Response Letter, Keeps Buy Rating	21-08-18	MT
Spectrum Pharmaceuticals : Reports Third Quarter 2015 Financial Results and Pipeline Update	15-11-04	BU
Spectrum Pharmaceuticals : Reports Second Quarter 2015 Financial Results and Pipeline Update	15-08-06	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer